Transcode Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Transcode Therapeutics Total Assets Growth & History (RNAZ)
Transcode Therapeutics's total assets was $162.4M for fiscal 2025.
View full Transcode Therapeutics company overviewTranscode Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $162.4M | $155.1M | +2126.32% |
| 2024 | 2024-12-31 | $7.3M | $2.1M | +41.10% |
| 2023 | 2023-12-31 | $5.2M | −$2.4M | −31.87% |
| 2022 | 2022-12-31 | $7.6M | −$15.4M | −66.92% |
| 2021 | 2021-12-31 | $22.9M | $21.9M | +2073.50% |
| 2020 | 2020-12-31 | $1.1M | — | — |
Transcode Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $151.0M | $142.7M | +1726.79% |
| Q1 2026 | 2026-03-31 | $157.2M | $144.0M | +1091.15% |
| Q4 2025 | 2025-12-31 | $162.4M | $155.1M | +2126.32% |
| Q3 2025 | 2025-09-30 | $5.2M | $1.3M | +32.79% |
| Q2 2025 | 2025-06-30 | $8.3M | $3.4M | +71.34% |
| Q1 2025 | 2025-03-31 | $13.2M | $5.9M | +80.98% |
| Q4 2024 | 2024-12-31 | $7.3M | $2.1M | +41.10% |
| Q3 2024 | 2024-09-30 | $3.9M | −$6.3M | −61.52% |
| Q2 2024 | 2024-06-30 | $4.8M | −$1.1M | −17.97% |
| Q1 2024 | 2024-03-31 | $7.3M | $1.7M | +30.41% |
| Q4 2023 | 2023-12-31 | $5.2M | −$2.4M | −31.87% |
| Q3 2023 | 2023-09-30 | $10.2M | −$1.8M | −14.88% |
| Q2 2023 | 2023-06-30 | $5.9M | −$8.3M | −58.45% |
| Q1 2023 | 2023-03-31 | $5.6M | −$13.3M | −70.34% |
| Q4 2022 | 2022-12-31 | $7.6M | −$15.4M | −66.92% |
| Q3 2022 | 2022-09-30 | $12.0M | −$13.3M | −52.62% |
| Q2 2022 | 2022-06-30 | $14.2M | $12.6M | +829.89% |
| Q1 2022 | 2022-03-31 | $18.9M | — | — |
| Q4 2021 | 2021-12-31 | $22.9M | $21.9M | +2073.50% |
| Q3 2021 | 2021-09-30 | $25.4M | — | — |
| Q2 2021 | 2021-06-30 | $1.5M | — | — |
| Q4 2020 | 2020-12-31 | $1.1M | — | — |
Transcode Therapeutics total assets trends
Over the last five fiscal years, Transcode Therapeutics's total assets increased from $1.1M to $162.4M, a change of $161.3M. The latest reported quarter, Q2 2026, shows $151.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transcode Therapeutics source filings ↗